290 related articles for article (PubMed ID: 24919568)
21. Skin barrier integrity and natural moisturising factor levels after cumulative dermal exposure to alkaline agents in atopic dermatitis.
Angelova-Fischer I; Dapic I; Hoek AK; Jakasa I; Fischer TW; Zillikens D; Kezic S
Acta Derm Venereol; 2014 Nov; 94(6):640-4. PubMed ID: 24531413
[TBL] [Abstract][Full Text] [Related]
22. The use of immunohistologic analysis in differentiating cutaneous T-cell lymphoma from psoriasis and dermatitis.
Verga M; Braverman IM
Arch Dermatol; 1991 Oct; 127(10):1503-10. PubMed ID: 1929457
[TBL] [Abstract][Full Text] [Related]
23. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
[TBL] [Abstract][Full Text] [Related]
24. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin.
Gambichler T; Skrygan M; Tomi NS; Othlinghaus N; Brockmeyer NH; Altmeyer P; Kreuter A
Int Arch Allergy Immunol; 2008; 147(1):17-24. PubMed ID: 18446049
[TBL] [Abstract][Full Text] [Related]
25. Locus 1q21 Gene expression changes in atopic dermatitis skin lesions: deregulation of small proline-rich region 1A.
Jarzab J; Filipowska B; Zebracka J; Kowalska M; Bozek A; Rachowska R; Gubala E; Grzanka A; Hadas E; Jarzab B
Int Arch Allergy Immunol; 2010; 151(1):28-37. PubMed ID: 19672094
[TBL] [Abstract][Full Text] [Related]
26. Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations.
Horimukai K; Morita K; Narita M; Kondo M; Kabashima S; Inoue E; Sasaki T; Niizeki H; Saito H; Matsumoto K; Ohya Y
Allergol Int; 2016 Jan; 65(1):103-8. PubMed ID: 26666481
[TBL] [Abstract][Full Text] [Related]
27. Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury.
Harder J; Dressel S; Wittersheim M; Cordes J; Meyer-Hoffert U; Mrowietz U; Fölster-Holst R; Proksch E; Schröder JM; Schwarz T; Gläser R
J Invest Dermatol; 2010 May; 130(5):1355-64. PubMed ID: 20107483
[TBL] [Abstract][Full Text] [Related]
28. TOX expression in different subtypes of cutaneous lymphoma.
Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799
[TBL] [Abstract][Full Text] [Related]
29. Reduced expression of epidermal growth factor receptor, E-cadherin, and occludin in the skin of flaky tail mice is due to filaggrin and loricrin deficiencies.
Nakai K; Yoneda K; Hosokawa Y; Moriue T; Presland RB; Fallon PG; Kabashima K; Kosaka H; Kubota Y
Am J Pathol; 2012 Sep; 181(3):969-77. PubMed ID: 22796440
[TBL] [Abstract][Full Text] [Related]
30. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year.
Kelleher M; Dunn-Galvin A; Hourihane JO; Murray D; Campbell LE; McLean WHI; Irvine AD
J Allergy Clin Immunol; 2015 Apr; 135(4):930-935.e1. PubMed ID: 25618747
[TBL] [Abstract][Full Text] [Related]
31. Are transepidermal water loss and clinical signs correlated in canine atopic dermatitis? A compilation of studies.
Marsella R
Vet Dermatol; 2012 Jun; 23(3):238-e49. PubMed ID: 22575022
[TBL] [Abstract][Full Text] [Related]
32. Serum visfatin levels in patients with atopic dermatitis and cutaneous T-cell lymphoma.
Suga H; Sugaya M; Miyagaki T; Kawaguchi M; Morimura S; Kai H; Kagami S; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
Eur J Dermatol; 2013; 23(5):629-35. PubMed ID: 24001451
[TBL] [Abstract][Full Text] [Related]
33. Sphingosylphosphorylcholine down-regulates filaggrin gene transcription through NOX5-based NADPH oxidase and cyclooxygenase-2 in human keratinocytes.
Choi H; Kim S; Kim HJ; Kim KM; Lee CH; Shin JH; Noh M
Biochem Pharmacol; 2010 Jul; 80(1):95-103. PubMed ID: 20230798
[TBL] [Abstract][Full Text] [Related]
34. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations.
Jakasa I; Koster ES; Calkoen F; McLean WH; Campbell LE; Bos JD; Verberk MM; Kezic S
J Invest Dermatol; 2011 Feb; 131(2):540-2. PubMed ID: 20962854
[No Abstract] [Full Text] [Related]
35. In vivo hydration and water-retention capacity of stratum corneum in clinically uninvolved skin in atopic and psoriatic patients.
Berardesca E; Fideli D; Borroni G; Rabbiosi G; Maibach H
Acta Derm Venereol; 1990; 70(5):400-4. PubMed ID: 1980973
[TBL] [Abstract][Full Text] [Related]
36. A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic dermatitis.
Naeem AS; Tommasi C; Cole C; Brown SJ; Zhu Y; Way B; Willis Owen SA; Moffatt M; Cookson WO; Harper JI; Di WL; Brown SJ; Reinheckel T; O'Shaughnessy RF
J Allergy Clin Immunol; 2017 Apr; 139(4):1228-1241. PubMed ID: 27913303
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement.
Laudańska H; Reduta T; Szmitkowska D
Rocz Akad Med Bialymst; 2003; 48():123-7. PubMed ID: 14737957
[TBL] [Abstract][Full Text] [Related]
38. Distinct barrier integrity phenotypes in filaggrin-related atopic eczema following sequential tape stripping and lipid profiling.
Angelova-Fischer I; Mannheimer AC; Hinder A; Ruether A; Franke A; Neubert RH; Fischer TW; Zillikens D
Exp Dermatol; 2011 Apr; 20(4):351-6. PubMed ID: 21410766
[TBL] [Abstract][Full Text] [Related]
39. Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma.
Jain S; Stroopinsky D; Yin L; Rosenblatt J; Alam M; Bhargava P; Clark RA; Kupper TS; Palmer K; Coll MD; Rajabi H; Pyzer A; Bar-Natan M; Luptakova K; Arnason J; Joyce R; Kufe D; Avigan D
Blood; 2015 Jul; 126(3):354-62. PubMed ID: 26048911
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of out-in skin transparency using a colorimeter and food dye in patients with atopic dermatitis.
Mochizuki H; Tadaki H; Takami S; Muramatsu R; Hagiwara S; Mizuno T; Arakawa H
Br J Dermatol; 2009 May; 160(5):972-9. PubMed ID: 19222458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
